AR047728A1 - Adyuvante antimicrobiano y uso de agentes antimicrobianos como adyuvante de vacunas - Google Patents
Adyuvante antimicrobiano y uso de agentes antimicrobianos como adyuvante de vacunasInfo
- Publication number
- AR047728A1 AR047728A1 ARP040104279A ARP040104279A AR047728A1 AR 047728 A1 AR047728 A1 AR 047728A1 AR P040104279 A ARP040104279 A AR P040104279A AR P040104279 A ARP040104279 A AR P040104279A AR 047728 A1 AR047728 A1 AR 047728A1
- Authority
- AR
- Argentina
- Prior art keywords
- assistant
- antimicrobial
- vaccine
- adjuvant
- composition
- Prior art date
Links
- 239000004599 antimicrobial Substances 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 6
- 230000002265 prevention Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000013566 allergen Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 239000012646 vaccine adjuvant Substances 0.000 abstract 1
- 229940124931 vaccine adjuvant Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composicion de adyuvantes que comprenden uno o más agentes antimicrobianos, en particular una azalida, en la que el agente antimicrobiano actua como un adyuvante, la composicion de adyuvantes es un adyuvante de vacunas. Además describe una vacuna que comprende varios componentes comprendiendo a) al menos un antígeno y b) al menos un agente antimicrobiano, en particular una azalida, en la que la azalida actua como un adyuvante. Una composicion de adyuvantes o vacuna de la presente, es util en la prevencion y tratamiento de enfermedades producidas por un agente patogeno, una célula cancerosa, o un alérgeno. Procedimiento de prevencion y kit que comprende la composicion de adyuvantes o vacunas descriptos anteriormente.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52409703P | 2003-11-21 | 2003-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR047728A1 true AR047728A1 (es) | 2006-02-15 |
Family
ID=34619630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040104279A AR047728A1 (es) | 2003-11-21 | 2004-11-19 | Adyuvante antimicrobiano y uso de agentes antimicrobianos como adyuvante de vacunas |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070141086A1 (es) |
| EP (1) | EP1689434A1 (es) |
| JP (1) | JP2007512312A (es) |
| KR (1) | KR100785601B1 (es) |
| CN (1) | CN1882360A (es) |
| AR (1) | AR047728A1 (es) |
| AU (1) | AU2004290982B2 (es) |
| BR (1) | BRPI0416205A (es) |
| CA (1) | CA2546195A1 (es) |
| IL (1) | IL175373A0 (es) |
| MX (1) | MXPA06005639A (es) |
| NO (1) | NO20062918L (es) |
| RU (1) | RU2322241C2 (es) |
| TW (1) | TW200526245A (es) |
| WO (1) | WO2005049081A1 (es) |
| ZA (1) | ZA200603065B (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| KR101108439B1 (ko) | 2002-10-25 | 2012-01-31 | 포믹스 리미티드 | 화장료 및 약제용 거품제 |
| FR2896416B1 (fr) * | 2006-01-24 | 2010-08-13 | Vetoquinol | Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| JP2011507816A (ja) * | 2007-12-21 | 2011-03-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | マラリア用ワクチン |
| CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| EP2482788B1 (en) | 2009-10-02 | 2022-12-14 | Journey Medical Corporation | Topical tetracycline compositions |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US9399057B2 (en) * | 2010-01-28 | 2016-07-26 | Universiteit Gent | Salmonella vaccine |
| CN103998056B (zh) * | 2011-07-22 | 2017-09-12 | 诺瓦蒂格姆疗法有限公司 | 用于接种抗金黄色葡萄球菌疫苗的方法和组合物 |
| AU2014240165A1 (en) * | 2013-03-14 | 2015-10-01 | Rongfu Wang | Methods and compositions for modulating regulatory T cell function |
| AU2014227748B2 (en) | 2013-03-15 | 2019-02-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for treating fungal and bacterial pathogens |
| CN103127098B (zh) * | 2013-03-22 | 2014-05-14 | 于法周 | 一种含有克拉维酸或其盐的抗癌药物组合物及制药用途 |
| EP2926815A1 (en) * | 2014-04-03 | 2015-10-07 | Institut Curie | New derivatives of cephalosporin for treating cancer |
| CN106999499A (zh) * | 2014-10-28 | 2017-08-01 | 湘北威尔曼制药股份有限公司 | 一种氧代哌嗪酰胺类化合物的用途 |
| CN105616414B (zh) * | 2014-10-28 | 2019-03-05 | 湘北威尔曼制药股份有限公司 | 一种氧代哌嗪酰胺类化合物的新用途 |
| CN104546863B (zh) * | 2015-02-09 | 2016-09-14 | 江苏澳格姆生物科技有限公司 | 头孢噻吩钠在制备抑制肿瘤细胞转移和扩散的药物中的应用 |
| US11278616B2 (en) | 2015-08-06 | 2022-03-22 | Nitto Denko Corporation | Immunity induction promoting composition, and vaccine pharmaceutical composition |
| WO2017116049A1 (ko) * | 2015-12-31 | 2017-07-06 | 경북대학교 산학협력단 | 설폰아마이드계 화합물을 유효성분으로 포함하는 암의 치료 및 전이 억제용 약학적 조성물 |
| EP3426287A4 (en) | 2016-03-09 | 2020-03-11 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | METHODS AND KITS FOR USE IN THE PREVENTION AND TREATMENT OF VULVO-VAGINAL CANDIDOSIS |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| CN110302376A (zh) * | 2019-04-22 | 2019-10-08 | 荆门市动物疫病预防控制中心 | 一种禽流感疫苗佐剂及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
| HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
| US6339063B1 (en) * | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
| UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
-
2004
- 2004-11-08 CA CA002546195A patent/CA2546195A1/en not_active Abandoned
- 2004-11-08 BR BRPI0416205-6A patent/BRPI0416205A/pt not_active IP Right Cessation
- 2004-11-08 WO PCT/IB2004/003694 patent/WO2005049081A1/en active Application Filing
- 2004-11-08 KR KR1020067009852A patent/KR100785601B1/ko not_active IP Right Cessation
- 2004-11-08 RU RU2006117339/15A patent/RU2322241C2/ru not_active IP Right Cessation
- 2004-11-08 CN CNA2004800341547A patent/CN1882360A/zh active Pending
- 2004-11-08 EP EP04798833A patent/EP1689434A1/en not_active Withdrawn
- 2004-11-08 JP JP2006540643A patent/JP2007512312A/ja not_active Withdrawn
- 2004-11-08 US US10/595,784 patent/US20070141086A1/en not_active Abandoned
- 2004-11-08 AU AU2004290982A patent/AU2004290982B2/en not_active Expired - Fee Related
- 2004-11-08 MX MXPA06005639A patent/MXPA06005639A/es not_active Application Discontinuation
- 2004-11-19 TW TW093135705A patent/TW200526245A/zh unknown
- 2004-11-19 AR ARP040104279A patent/AR047728A1/es not_active Application Discontinuation
-
2006
- 2006-04-18 ZA ZA200603065A patent/ZA200603065B/xx unknown
- 2006-05-01 IL IL175373A patent/IL175373A0/en unknown
- 2006-06-21 NO NO20062918A patent/NO20062918L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20062918L (no) | 2006-08-21 |
| IL175373A0 (en) | 2006-09-05 |
| AU2004290982A1 (en) | 2005-06-02 |
| JP2007512312A (ja) | 2007-05-17 |
| MXPA06005639A (es) | 2006-08-17 |
| RU2006117339A (ru) | 2007-12-10 |
| WO2005049081A1 (en) | 2005-06-02 |
| CN1882360A (zh) | 2006-12-20 |
| AU2004290982B2 (en) | 2008-06-19 |
| BRPI0416205A (pt) | 2006-12-26 |
| US20070141086A1 (en) | 2007-06-21 |
| EP1689434A1 (en) | 2006-08-16 |
| RU2322241C2 (ru) | 2008-04-20 |
| ZA200603065B (en) | 2007-08-29 |
| CA2546195A1 (en) | 2005-06-02 |
| KR20060091001A (ko) | 2006-08-17 |
| KR100785601B1 (ko) | 2007-12-14 |
| TW200526245A (en) | 2005-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR047728A1 (es) | Adyuvante antimicrobiano y uso de agentes antimicrobianos como adyuvante de vacunas | |
| CO6160335A2 (es) | Vacuna | |
| AR065319A1 (es) | Prevencion y tratamiento de pcvd subclinica | |
| CL2016000650A1 (es) | Composicion de vacuna que comprende un antigeno y una formulacion coadyuvante, que comprende al menos el 50 % v/v de una fase oleosa, monofosforil-lipido a (mpl-a) o un analogo del mismo y un oligonucleotido inmunoestimulate; y uso de la composición de vacuna para preparar un medicamento. | |
| ES2585810T3 (es) | Uso de un virus de la gripe y un adyuvante de emulsión de aceite en agua para inducir respuesta de células T CD4 y/o una respuesta de células B de memoria mejorada | |
| BRPI0208183B8 (pt) | peptídeo antígeno de câncer modificado por wt1 e vacinas para câncer | |
| CR10181A (es) | Anticuerpos anti-il-23 humanos, composiciones, metodos y usos | |
| CL2013002106A1 (es) | Composicion inmunogenica de streptococcus pneumoniae que comprende 2 o mas conjugados de sacarido capsular de diferentes serotipos; vacuna que la comprende; procedimiento de fabricacion; y su uso para tratar o prevenir enfermedades causadas por la infeccion por streptococcus pneumoniae (div.sol.n°3625-2006). | |
| CL2007001698A1 (es) | Composicion inmunogenica que comprende los lipooligosacaridos meningococicos (los) de inmunotipos l2 y l3 de cepas neissericas; composicion de vacuna que la comprende; procedimiento de preparacion; y su uso para la prevencion o tratamiento de enfermedades causadas por uno o mas serogrupos de n. meningitidis. | |
| ES2195169T3 (es) | Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion. | |
| BRPI0414062A (pt) | uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv | |
| CR10101A (es) | Nueva composición | |
| CL2008001855A1 (es) | Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa. | |
| CL2010000657A1 (es) | Composicion inmunogenica efectiva contra una infeccion por pcv2 que comprende al menos 0,2 ug de proteina recombinante orf2 de pcv2 (divisional solicitud 3475-05). | |
| AR059688A1 (es) | Uso de alfa - toxina para tratar y prevenir las infecciones por staphylococcus | |
| PT1187629E (pt) | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador | |
| AR057586A1 (es) | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina | |
| PE20190458A1 (es) | Composiciones de neisseria meningitidis y metodos de las mismas | |
| BRPI0509053A (pt) | composição farmacêutica anidra e uso de um agente siliconado e de uma composição | |
| AR054844A1 (es) | Vacuna contra lawsonia y metodos de uso de la misma | |
| UY27843A1 (es) | Composicion de vacuna | |
| UY32208A (es) | Uso de antigeno de mycoplasma bovis | |
| ATE521621T1 (de) | Cpg-einzelstrang-desoxynukleotide zur verwendung als adjuvans | |
| ECSP066805A (es) | Compuestos silinano como inhibidores de cisteína proteasa | |
| AR034200A1 (es) | Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |